Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: Preparation, characterisation andin vivoevaluation of their effectiveness in the treatment of chronic osteomyelitis
Authors:
- Erdal CevherECErdal Cevher
- Zafer OrhanZOZafer Orhan
- Demet ŞensoyDŞDemet Şensoy
- Rengin AhiskaliRARengin Ahiskali
- Pei Lee KanPKPei Lee Kan
- Olcay SağirliOSOlcay Sağirli
- Lütfiye MülazimoğluLMLütfiye Mülazimoğlu
- 1 January 2007
- journal article
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 24 (6) , 577-595
Abstract
The aim of this study was to prepare poly(D,L-lactide-co-glycolide) (PLGA) microspheres containing sodium fusidate (SF) using a double emulsion solvent evaporation method with varying polymer:drug ratios (1:1, 2.5:1, 5:1) and to evaluate its efficiency for the local treatment of chronic osteomyelitis. The particle size and distribution, morphological characteristics, thermal behaviour, drug content, encapsulation efficiency and in vitro release assessments of the formulations had been carried out. Sterilized SF-PLGA microspheres were implanted in the proximal tibia of rats with methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis. After 3 weeks of treatment, bone samples were analysed with a microbiological assay. PLGA microspheres between the size ranges of 2.16-4.12 microm were obtained. Production yield of all formulations was found to be higher than 79% and encapsulation efficiencies of 19.8-34.3% were obtained. DSC thermogram showed that the SF was in an amorphous state in the microspheres and the glass transition temperature (T(g)) of PLGA was not influenced by the preparation procedure. In vitro drug release studies had indicated that these microspheres had significant burst release and their drug release rates were decreased upon increasing the polymer:drug ratio (p < 0.05). Based on the in vivo data, rats implanted with SF-PLGA microspheres and empty microspheres showed 1987 +/- 1196 and 55526 +/- 49086 colony forming unit of MRSA in 1 g bone samples (CFU/g), respectively (p < 0.01). The in vitro and in vivo studies had shown that the implanted SF loaded microspheres were found to be effective for the treatment of chronic osteomyelitis in an animal experimental model. Hence, these microspheres may be potentially useful in the clinical setting.Keywords
This publication has 36 references indexed in Scilit:
- The preparation of ciprofloxacin hydrochloride-loaded chitosan and pectin microspheresThe Journal of Bone and Joint Surgery. British volume, 2006
- Two-month ciprofloxacin implants for multibacterial bone infectionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Efficacy of antibiotics-loaded interpenetrating network (IPNs) hydrogel based on poly(acrylic acid) and gelatin for treatment of experimental osteomyelitis: in vivo studyBiomaterials, 2005
- Vancomycin biodegradable poly(lactide-co-glycolide) microparticles for bone implantation. Influence of the formulation parameters on the size, morphology, drug loading andin vitroreleaseJournal of Microencapsulation, 2005
- Prevention and treatment of experimental osteomyelitis in dogs with ciprofloxacin‐loaded crosslinked high amylose starch implantsJournal of Orthopaedic Research, 2004
- Treatment of Osteomyelitis With Local Antibiotics Delivered Via Bioabsorbable PolymerClinical Orthopaedics and Related Research, 2003
- In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitisBiomaterials, 2000
- Use of a bioabsorbable polymer for the delivery of ofloxacin during experimental osteomyelitis treatmentJournal of Orthopaedic Research, 1998
- Local Antibacterial Therapy for the Management of Orthopaedic InfectionsClinical Pharmacokinetics, 1995
- Experimental Osteomyelitis. I. A Description of the ModelThe Journal of Infectious Diseases, 1970